From the European Society for Blood and Marrow Transplantation (EBMT) 2018 Annual Meeting, held in Lisbon, Portugal, Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, discusses the diagnostic approach for chronic graft-versus-host disease (GvHD).
